Contravisory Investment Management Inc. Purchases Shares of 6,539 Henry Schein, Inc. (NASDAQ:HSIC)

Contravisory Investment Management Inc. bought a new stake in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 6,539 shares of the company's stock, valued at approximately $448,000.

Several other institutional investors also recently modified their holdings of HSIC. Robeco Institutional Asset Management B.V. acquired a new stake in Henry Schein during the fourth quarter worth approximately $763,000. Tokio Marine Asset Management Co. Ltd. boosted its position in shares of Henry Schein by 13.1% in the fourth quarter. Tokio Marine Asset Management Co. Ltd. now owns 4,675 shares of the company's stock valued at $324,000 after acquiring an additional 541 shares during the period. Mather Group LLC. raised its stake in Henry Schein by 43.7% in the 4th quarter. Mather Group LLC. now owns 1,503 shares of the company's stock worth $104,000 after purchasing an additional 457 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. grew its position in shares of Henry Schein by 29.9% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 15,854 shares of the company's stock worth $1,113,000 after purchasing an additional 3,650 shares in the last quarter. Finally, Private Management Group Inc. raised its position in shares of Henry Schein by 5.7% in the fourth quarter. Private Management Group Inc. now owns 350,515 shares of the company's stock valued at $24,256,000 after buying an additional 18,882 shares in the last quarter. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on HSIC shares. UBS Group dropped their price objective on Henry Schein from $83.00 to $80.00 and set a "neutral" rating for the company in a report on Wednesday, February 26th. Wall Street Zen downgraded Henry Schein from a "buy" rating to a "hold" rating in a research note on Thursday, April 17th. Piper Sandler cut their price objective on shares of Henry Schein from $83.00 to $77.00 and set an "overweight" rating for the company in a research report on Wednesday, April 30th. Barrington Research reduced their price objective on shares of Henry Schein from $90.00 to $86.00 and set an "outperform" rating on the stock in a research note on Tuesday, May 6th. Finally, Wells Fargo & Company dropped their target price on shares of Henry Schein from $80.00 to $75.00 and set an "equal weight" rating for the company in a research report on Tuesday, May 6th. Six research analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, Henry Schein presently has a consensus rating of "Moderate Buy" and an average target price of $79.30.

Insiders Place Their Bets

In related news, Director Philip A. Laskawy sold 2,604 shares of the stock in a transaction on Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total value of $184,988.16. Following the completion of the sale, the director now directly owns 24,805 shares in the company, valued at $1,762,147.20. This represents a 9.50% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Bradford C. Connett sold 4,036 shares of the stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total value of $287,161.40. Following the completion of the sale, the chief executive officer now directly owns 62,688 shares of the company's stock, valued at approximately $4,460,251.20. The trade was a 6.05% decrease in their position. The disclosure for this sale can be found here. Insiders own 1.08% of the company's stock.

Henry Schein Price Performance

Shares of HSIC traded up $0.08 during mid-day trading on Thursday, reaching $70.47. The company had a trading volume of 865,137 shares, compared to its average volume of 1,684,179. The company has a market capitalization of $8.58 billion, a price-to-earnings ratio of 29.00, a P/E/G ratio of 2.13 and a beta of 0.87. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. The company's 50 day simple moving average is $67.75 and its 200 day simple moving average is $71.66. Henry Schein, Inc. has a 1-year low of $60.56 and a 1-year high of $82.49.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its earnings results on Monday, May 5th. The company reported $1.15 earnings per share for the quarter, topping analysts' consensus estimates of $1.11 by $0.04. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The firm had revenue of $3.17 billion for the quarter, compared to analysts' expectations of $3.24 billion. During the same quarter in the previous year, the firm posted $1.10 earnings per share. The company's revenue was down .1% on a year-over-year basis. Analysts expect that Henry Schein, Inc. will post 4.74 EPS for the current year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.